# The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

> **NCT01215383** · — · UNKNOWN · sponsor: **Ziv Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01215383
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215383, "The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01215383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*